Cell-Specific In Vivo Gene Delivery & Genome Editing via Retargetable Fusogens

Time: 9:30 am
day: Day 2


• Highlight the in vivo delivery platform that Sana has developed for gene therapy

• Discuss progress in targeting T Cells and HSCs

• Provide examples of pre-clinical studies with delivery of integrating vectors and Gene editing machinery